S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
about
Multiple sclerosis: the role of cytokines in pathogenesis and in therapiesFingolimod (FTY720) enhances remyelination following demyelination of organotypic cerebellar slices.Effect of staurosporine in the morphology and viability of cerebellar astrocytes: role of reactive oxygen species and NADPH oxidase.Plasma gelsolin modulates cellular response to sphingosine 1-phosphate.Fingolimod for relapsing multiple sclerosis: an update.Regulation of mammalian physiology, development, and disease by the sphingosine 1-phosphate and lysophosphatidic acid receptors.Current status of the immunomodulation and immunomediated therapeutic strategies for multiple sclerosis.Regulation of connexin43 gap junctional communication by phosphatidylinositol 4,5-bisphosphateSphingolipids and membrane biology as determined from genetic models.Lysophosphatidic acid receptor-dependent secondary effects via astrocytes promote neuronal differentiationInterferon-gamma inhibits enterocyte migration by reversibly displacing connexin43 from lipid rafts.Sphingosine 1-phosphate potentiates human lung fibroblast chemotaxis through the S1P2 receptor.Pathway specific modulation of S1P1 receptor signalling in rat and human astrocytes.A role for connexin43 in macrophage phagocytosis and host survival after bacterial peritoneal infection.RhoA GTPase and F-actin dynamically regulate the permeability of Cx43-made channels in rat cardiac myocytesFTY720 (fingolimod) for relapsing multiple sclerosis.Clinicopathologic significance of claudin-6, occludin, and matrix metalloproteinases -2 expression in ovarian carcinoma.FTY720 (fingolimod) in Multiple Sclerosis: therapeutic effects in the immune and the central nervous systemFingolimod for the treatment of relapsing multiple sclerosis.Neuron-astroglial interactions in cell-fate commitment and maturation in the central nervous system.Influence of drugs on gap junctions in glioma cell lines and primary astrocytes in vitro.Regulation of human glia by multiple sclerosis disease modifying therapies.Chemerin-induced arterial contraction is Gi- and calcium-dependent.Activation of S1P₁ receptor regulates PI3K/Akt/FoxO3a pathway in response to oxidative stress in PC12 cells.Derivation of Functional Human Astrocytes from Cerebral Organoids.Non-dioxin-like organic toxicant PCB153 modulates sphingolipid metabolism in liver progenitor cells: its role in Cx43-formed gap junction impairment.[Oral fingolimod in multiple sclerosis: therapeutic modulation of the sphingosine-1-phosphate system].Sphingosine 1-phosphate-primed astrocytes enhance differentiation of neuronal progenitor cells.Sphingosine-1-phosphate induces Ca2+ signaling and CXCL1 release via TRPC6 channel in astrocytes.The cyclic GMP-protein kinase G pathway regulates cytoskeleton dynamics and motility in astrocytes.Connexin 30 controls astroglial polarization during postnatal brain development.An Easy-to-Implement Protocol for Preparing Postnatal Ventral Mesencephalic Cultures.A Functionally Defined Astrocyte Population Identified by c-Fos Activation in a Mouse Model of Multiple Sclerosis Modulated by S1P Signaling: Immediate-Early Astrocytes ()Emerging PET Radiotracers and Targets for Imaging of Neuroinflammation in Neurodegenerative Diseases: Outlook Beyond TSPO
P2860
Q27011014-AE55DBF1-1F92-4A0A-8D58-228674B8260AQ33882403-089A5458-91F2-47FE-8A33-DC9F226B0270Q34119306-758E0B5C-AD19-48DE-9D03-2BB249E18917Q34426423-CB1FD968-06DD-4A04-9F75-0F4C69C502B8Q34618474-B4B7FD72-0062-4728-B436-5A64C823CB79Q35551835-CBEE63FC-633F-4976-B27F-C08E0045FE1CQ35606563-CB12B802-E151-417F-B749-F128990E90A0Q36118459-5E53B75F-2EF1-40A3-8EE6-64F31C285F0BQ36459028-FF6D1E02-F493-4A8F-97C3-4C7ECFD2F67EQ36512021-45690CD1-6FD0-4DA8-BE55-64C6C43B43D8Q36877288-E56C63E5-8D12-4F5A-A127-A07FDA34D7C1Q36890026-EEC45CF7-009C-4A23-A8D7-1B2948EE011FQ36965917-A3208107-F80A-44A3-9065-8508CC238235Q36970937-3BCF1312-3003-43FC-AB50-488734CAD876Q37142706-178D9192-C89A-43B5-A2CF-CCF9F2309CD6Q37154788-C3D0BE4F-A081-4894-BDB8-DC71CFCC6916Q37400120-EEE5F917-CD06-4743-B2DE-E84DB53C296CQ37611085-0626D49D-BF71-4DEF-8FCF-8AE2A99349B8Q37821010-CD593443-6F6A-4DE0-A7E6-762D37CD8B50Q38012043-AB286409-5654-46A2-B56E-5A0DF517662FQ38218094-91170721-D82C-43F7-BF35-5D9D5F3699F0Q38563863-3483C389-0CE8-42B0-9549-00AFFCA911E5Q39150819-5433D086-16D2-466D-84A6-57290E1DD245Q41656417-9AB1C920-F7E1-41D1-936C-F71FF4D068ECQ42314257-953A2C09-5591-4A06-88C5-EF9493091C33Q42695768-D27BF3AB-8776-41C7-A0D4-9A17364C0E5CQ43838770-B96D829E-27AC-4A30-BF26-860A82D44AA6Q47759930-601A861E-DEDD-4703-B996-FC1926B96F54Q48116985-C4AA67E4-3E93-40B3-A559-81B1F733378DQ48138226-FD976A95-5E2D-4A42-9671-94BD03FF0D3FQ51738444-6ABB6396-BAC3-415F-8AC1-201F32FE20BBQ52647790-0DF32843-C33D-449C-A14D-AFBBF0669842Q58701288-FF392409-5F1E-46F8-A313-B463AA4AE6CFQ58751451-058B69B1-D859-4FA1-A086-84E1A43D80FB
P2860
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年学术文章
@wuu
2006年学术文章
@zh
2006年学术文章
@zh-cn
2006年学术文章
@zh-hans
2006年学术文章
@zh-my
2006年学术文章
@zh-sg
2006年學術文章
@yue
2006年學術文章
@zh-hant
name
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
@en
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
@nl
type
label
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
@en
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
@nl
prefLabel
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
@en
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
@nl
P2093
P2860
P50
P1476
S1P inhibits gap junctions in astrocytes: involvement of G and Rho GTPase/ROCK.
@en
P2093
Eric Etienne
Jocelyne Cordier
Martine Tencé
Nathalie Rouach
William Même
P2860
P304
P356
10.1111/J.1460-9568.2006.04671.X
P407
P577
2006-03-01T00:00:00Z